Jay Named AAPS Fellow

Monday, October 09, 2006 - Michael Jay, Ph.D., professor of pharmaceutical sciences and director of the Center for Pharmaceutical Science and Technology (CPST) at the University of Kentucky College of Pharmacy, will be conferred as Fellow of the American Association of Pharmaceutical Scientists (AAPS) at the organization's annual meeting in San Antonio, Oct. 29 - Nov. 2.

AAPS confers the honor of Fellow to recognize individuals for outstanding contributions that elevate the stature of the pharmaceutical sciences and for professional excellence in the field relevant to the mission of AAPS.

In more than 25 years as a UK faculty member, Dr. Jay has been involved in the discovery, development and evaluation of pharmaceuticals agents and has engaged in many objective-driven projects with the pharmaceutical industry. He is the author of more than 100 peer-reviewed publications, and 150 abstracts and presentations. He also holds nine awarded or pending patents and is a recipient of the Berson-Yalow Award from the Society of Nuclear Medicine, the Mendell Award for Pharmaceutical Technology, the CP Schaufus Grant from the Parenteral Drug Association Foundation, and the Distinguished Service Award from the Bluegrass Pharmaceutical Association.

Dr. Jay currently serves as executive director for economic development and innovations management in the UK College of Pharmacy and has held several leadership posts including director of graduate studies for the Pharmaceutical Sciences Graduate Program, controlled substances officer for the college, and coordinator of an NIH-sponsored minority high school research apprenticeship training program. He currently serves on the UK College of Pharmacy Executive Committee and has served on the UK Medical Center Research Advisory Committee.

Dr. Jay holds a B.S. in pharmacy from the State University of New York at Buffalo and is a registered pharmacist in New York and Kentucky. He earned his Ph.D. in pharmaceutical sciences at UK in 1980. He also was a visiting scientist at Oak Ridge Associated Universities and spent one and a half years as an assistant professor of nuclear medicine at the University of Connecticut.

In addition, he is co-founder, along with Dr. Russell Mumper, of NanoMed Pharmaceuticals Inc., an early-stage advanced drug delivery company using nanotechnology, thin film composites and film-forming gels to enable the development of new drugs and vaccines and to improve existing drugs.

Source: University of Kentucky College of Pharmacy News